Predicting outcomes of peritoneal-dialysis-associated peritonitis based on dialysate white blood cell count

摘要

Consecutive patients undergoing peritoneal dialysis who developed peritonitis at the Prince of Wales Hospital, Hong Kong, between August 2001 and July 2005 were retrospectively analyzed. Peritonitis was initially treated with intraperitoneal cefazolin and ceftazidime, and oral nystatin. Agents were adjusted after identification of the causative organism; treatment continued for -14 days (or >21 days if Staphylococcus aureus, Pseudomonas spp. or Xanthomonas spp. were isolated).